Walking impairment

This was a web-based study to look at the impact of neurological impairments from the perspectives of people with MS and their "care partners" ["I don't like this word"]. 

The study included 1011 people with MS and 317 care partners. 
Conclusions: Difficulty walking is a common impairment in people with MS, with adverse effects on the quality of life of MS'ers and their care partners. 

Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011 Sep 1;4(3):189-201.

"This study was sponsored by Acorda Therapeutics, the company that markets Fampridine in the US."

"The study may be biased towards more disabled MS'ers."

"These figures are a startling reminder of how disabling MS is and how disconnected neurologists are from these problems."

CoI: Multiple